<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Epidemiology and biological characteristics of SARS-CoV, MERS-CoV and SARS-CoV-2, as of 16 May 2020.</p>
 </caption>
 <alt-text id="alttext0040">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="2">Characteristic</th>
    <th>SASR-CoV</th>
    <th>MERS-CoV</th>
    <th>SARS-CoV-2</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="5">Clinical epidemiology</td>
    <td>Total global number</td>
    <td>8096</td>
    <td>2494</td>
    <td>4,434,653</td>
   </tr>
   <tr>
    <td>Number of deaths</td>
    <td>774</td>
    <td>858</td>
    <td>302,169</td>
   </tr>
   <tr>
    <td>Mortality</td>
    <td>9.6%</td>
    <td>34.4%</td>
    <td>6.8%</td>
   </tr>
   <tr>
    <td>Affected countries</td>
    <td>29</td>
    <td>27</td>
    <td>216</td>
   </tr>
   <tr>
    <td>Transmission region</td>
    <td>Globally</td>
    <td>Regionally</td>
    <td>Globally</td>
   </tr>
   <tr>
    <td colspan="2">The predominant cell receptor</td>
    <td>Human angiotensin-converting enzyme 2 (ACE2)</td>
    <td>Human dipeptidyl peptidase 4 (DPP4 or CD26)</td>
    <td>Human angiotensin-converting enzyme 2 (ACE2)</td>
   </tr>
   <tr>
    <td colspan="2">Receptor binding affinity</td>
    <td>High</td>
    <td>High</td>
    <td>Higher than SARS-CoV</td>
   </tr>
   <tr>
    <td colspan="2">PathogenicÂ mechanism</td>
    <td>Primarily infects ciliated bronchial epithelial cells and type II pneumocytes, resulting in massive viral replication and cell damage</td>
    <td>Primarily infects unciliated bronchial epithelial cells and type II pneumocytes, resulting in massive viral replication and cell damage</td>
    <td>Primarily infects ciliated bronchial epithelial cells and type II pneumocytes, resulting in massive viral replication and cell damage</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
